GLMA’s Alex Sheldon Headlines 11th Annual Advancing Excellence in Transgender Health Conference
The National LGBTQIA+ Health Education Center at The Fenway Institute is holding its 11th annual Advancing Excellence in Transgender Health: A Course for the Whole Care
Sharp Vision = Sharp Minds
As backpacks get packed and pencils get sharpened, don’t forget one of the most important school supplies—clear vision! Our elite team of Optometrists at Fenway
Fenway Celebrates National Health Center Week 2025
Fenway Health is excited to join in the nationwide celebration of America’s 1,400 community health centers (CHCs) during National Health Center Week 2025. Taking place August
Fenway Health Successfully Renews Patient Centered Medical Home Recognition and Distinction in Behavioral Health Integration
We are very happy to share that Fenway has once again successfully renewed our NCQA Patient Centered Medical Home (PCMH) Recognition for our location at
Coming Soon: YEZTUGO, the First Twice-Yearly Injectable PrEP
Fenway Health is proud to share that the FDA has just approved YEZTUGO, the first long-acting injectable PrEP medication administered just twice a year. This is
Fenway Health Commends Supreme Court Braidwood Decision Preserving Access to PrEP & Other Preventive Care
Fenway Health joins healthcare organizations across the country in commending the Supreme Court’s decision in Kennedy v. Braidwood to protect Affordable Care Act (ACA) requirements
Fenway Health Only New England Site Involved in Study Demonstrating Efficacy of Lenacapravir Twice-Yearly PrEP Injection
On June 18, the US Food and Drug Administration (FDA) approved the use of Gilead’s anti-HIV medication, Lenacapravir (trade name: Yeztugo) as a twice-yearly subcutaneous
Fenway Health Statement on Supreme Court U.S. v Skrmetti Decision
The Supreme Court of the United States issued a decision today in U.S. v Skrmetti to uphold Tennessee’s discriminatory ban on evidence-based, life-saving care for